Prevoznik Michael E's Form 4 filing
Quest Diagnostics Inc (DGX) · filed Dec 2, 2024
- Accession no.
- 0001022079-24-000208
- Filed
- Dec 2, 2024
- Trade date
- Nov 29, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.73M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Prevoznik Michael ECIK 0001222679 | Officer (SVP & General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2024 | Common Stock | MOption exerciseAcquired | +35,146 | $86.63 | +$3,044,697.98 | 73,624 | Direct | |
| Nov 29, 2024 | Common Stock | SSaleDisposed | −3,009 | $162.26F2 | −$488,240.34 | 70,615 | Direct | |
| Nov 29, 2024 | Common Stock | SSaleDisposed | −32,137 | $163.15F3 | −$5,243,151.55 | 38,478 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2024 | Common Stock | MOption exerciseDisposed | −35,146 | $86.63 | −$3,044,697.98 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $161.690 to $162.680. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $162.705 to $163.615. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.